ArticlePharmacological reports : PR2025

In vitro repositioning therapy with olaparib, temozolomide and oxaliplatin in glioblastoma cell lines: U118, U87, U251, H4 and human fibroblasts.

Anna Zając-Grabiec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.